Cosmo symbol
Hero background
Cosmo logo
About Us

Health confidence.
For everyone.

Manufacturing

At Cosmo, we go beyond tackling medical conditions; we empower life-changing confidence - for patients, healthcare professionals and partners. We harness science and AI to enable millions to take control of their gut, skin, and hair health -physically and emotionally - so they can live and work with confidence.

Breakthroughs.
Built together.

Breakthroughs

Minds with
purpose, unite.

Our teams are united by a common goal - to relentlessly pursue solutions that help people live and work with confidence.

MedTech AI

Plus Icon

Dermatology

Plus Icon

Gastroenterology

Plus Icon

CDMO

Plus Icon
Company

Driven by innovation.
Focused on impact.

At Cosmo, we innovate with purpose - to improve lives, advance care, and develop solutions where they're needed most.
Our work addresses some of the most persistent and high-impact health challenges that carry lasting physical, emotional, and psychological impact. By combining a deep understanding of science and technology, we are advancing research and therapeutic innovation that supports healthcare professionals and the patients they serve.

Slide icon

Colonic Infections

Plus button
Slide icon

Acne

Plus button
Slide icon

Androgenetic Alopecia (AGA)

Plus button
Slide icon

Colorectal cancer (CRC)

Plus button
Slide icon

Inflammatory Bowel Disease (IBD)

Plus button

[1] The American Cancer Society medical and editorial content team. “Key Statistics for Colorectal Cancer”. www.cancer.org. February 21, 2018. Web. November 21, 2019.

[2] Cancer.Net Editorial Board. “Colorectal Cancer: Statistics”. www.cancer.net. November, 2018. Web. November 21, 2019.

[3] Cancer Research UK. “Bowel cancer survival statistics”. www.cancerresearchuk.org. February 6, 2017. Web. November 21, 2019.

[4] Finlay A Macrae. “Colorectal cancer: Epidemiology, risk factors, and protective factors”. www.uptodate.com. September 20, 2019. Web. November 21, 2019.

[5] Hewings-Martin, Yella. “IBS: Five facts you need to know”. www.medicalnewstoday.com. MedicalNewsToday, November 29, 2017. Web. November 21, 2019.

[6] National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention. “Inflammatory Bowel Disease Prevalence (IBD) in the United States”. www.cdc.gov. March 21, 2019. Web. November 21, 2019.

[7] Connor, Bradley A. “Travelers’ Diarrhea”, Yellow Book. www.cdc.gov. June 24, 2019. Web. November 21, 2019.

Investors

Key Financial Data

€267M

Revenue for 2024

Financial Reports

Annual Report 2024

21 Mar 2025

Financial Reports

ESG Report 2024

21 Mar 2025

Financial Reports

Analyst Coverage

List of analysts
covering Cosmo

Read More

Governance

Confidence in
every department

Read More

Share Price

Cosmo Orange

Events & Presentations

Explore our upcoming and previous events

See all events

1 July 2025

Investor Day 2025

See event

Be the first to know what's new at Cosmo

Learn more
about Cosmo

Explore Cosmo's divisions, full portfolio and pipeline on our legacy sites while we build something new.

© 2025 Cosmo Pharmaceuticals. All right reserved.

LinkedInYoutubeX